Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee for Pivotal Phase lll Clinical Trial for Firdapse(TM)

[at noodls] – CORAL GABLES, Fla., March 27, 2013 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel … more

View todays social media effects on CPRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Catalyst is hiring next, click here to view